4.6 Review

The Role of Fusobacterium nucleatum in Colorectal Cancer Cell Proliferation and Migration

Related references

Note: Only part of the references are listed.
Article Cell Biology

Colorectal cancer-associated fibroblasts promote metastasis by up-regulating LRG1 through stromal IL-6/STAT3 signaling

Beiping Zhong et al.

Summary: Cancer-associated fibroblasts (CAFs) play a crucial role in colorectal cancer (CRC) metastasis by inducing the expression of Leucine Rich Alpha-2-Glycoprotein 1 (LRG1), which promotes CRC migration and invasion through epithelial-mesenchymal transition (EMT). The CAFs-mediated IL-6-STAT3-LRG1 axis is responsible for the up-regulation of LRG1 in CRC, and higher LRG1 expression predicts poor clinical outcomes, especially distant metastasis free survival in CRC patients.

CELL DEATH & DISEASE (2022)

Article Gastroenterology & Hepatology

Fusobacterium nucleatum promotes colon cancer progression by changing the mucosal microbiota and colon transcriptome in a mouse model

Na Wu et al.

Summary: In this study, it was demonstrated that F. nucleatum infection altered the colon mucosal microbiota by enriching pathogens related to the development of CRC, providing new insights into the role of F. nucleatum in the oncogenic microbial environment of the colon.

WORLD JOURNAL OF GASTROENTEROLOGY (2022)

Article Multidisciplinary Sciences

Fusobacterium nucleatum reduces METTL3-mediated m6A modification and contributes to colorectal cancer metastasis

Shujie Chen et al.

Summary: The study reveals that Fusobacterium nucleatum contributes to colorectal cancer (CRC) progression by reducing global m(6)A modifications through a YAP/FOXD3/METTL3/KIF26B axis. Fusobacterium nucleatum is closely associated with the development of CRC.

NATURE COMMUNICATIONS (2022)

Article Microbiology

Fusobacterium nucleatum Affects Cell Apoptosis by Regulating Intestinal Flora and Metabolites to Promote the Development of Colorectal Cancer

Tingting Yu et al.

Summary: This study examined the composition of intestinal flora and their metabolites in CRC patients, and found that the alteration of intestinal flora can affect the concentrations of metabolites such as lactic acid and propionic acid, which in turn impact the apoptosis of CRC cells and the progression of CRC.

FRONTIERS IN MICROBIOLOGY (2022)

Article Gastroenterology & Hepatology

Fusobacterium nucleatum promotes colorectal cancer cells adhesion to endothelial cells and facilitates extravasation and metastasis by inducing ALPK1/NF-κB/ICAM1 axis

Ying Zhang et al.

Summary: This study reveals that Fusobacterium nucleatum enhances the adhesion of colorectal cancer cells to endothelial cells and promotes tumor metastasis through the induction of ICAM1 expression. Mechanistically, F. nucleatum induces a new pattern recognition receptor ALPK1 to activate the NF-kappa B pathway, leading to the upregulation of ICAM1. High expression of ALPK1 or ICAM1 is associated with a shorter overall survival time of colorectal cancer patients.

GUT MICROBES (2022)

Article Multidisciplinary Sciences

Salivary Fusobacterium nucleatum serves as a potential biomarker for colorectal cancer

Xin Zhang et al.

Summary: Research has shown a close association between an increase in salivary Fn DNA and the onset of CRC, making Fn DNA a potential noninvasive diagnostic and prognostic biomarker for CRC patients. Transcriptome sequencing revealed significant differences in mRNA expression in tumor tissues between CRC patients with high and low levels of Fn infection.

ISCIENCE (2022)

Article Cell Biology

Long non-coding RNA EVADR induced by Fusobacterium nucleatum infection promotes colorectal cancer metastasis

Xiaoxue Lu et al.

Summary: This study found that F. nucleatum can promote the metastasis of colorectal cancer cells to the liver and lung, and it can be detected in the colonization of CRC metastasis in mouse models. Furthermore, F. nucleatum also upregulates the expression of EVADR, further enhancing the metastatic ability of CRC cells. The study also revealed that F. nucleatum-induced EVADR promotes colorectal cancer metastasis through a YBX1-dependent translation mechanism.

CELL REPORTS (2022)

Article Oncology

Fusobacterium nucleatum induces excess methyltransferase-like 3-mediated microRNA-4717-3p maturation to promote colorectal cancer cell proliferation

Qiaolin Xu et al.

Summary: This study reveals that Fusobacterium nucleatum infection promotes colorectal cancer (CRC) progression by upregulating microRNA-4717-3p (miR-4717) expression. MiR-4717 enhances CRC cell proliferation by directly inhibiting tumor suppressor MAP2K4. Additionally, METTL3-dependent m(6)A methylation facilitates the maturation of pri-miR-4717, which further promotes CRC cell proliferation through the miR-4717/MAP2K4 pathway.

CANCER SCIENCE (2022)

Review Biochemistry & Molecular Biology

The Oncobiome in Gastroenteric and Genitourinary Cancers

Domenica Lucia D'Antonio et al.

Summary: Early evidence suggests a strong association between microorganisms and human cancers. Bacterial dysbiosis in the gastrointestinal tract can lead to tumor-permissive environments, while genital and urinary dysbiosis may play a role in the pathogenesis of reproductive and urinary cancers. Modulating the microbiome could improve cancer treatment response and quality of life.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Biotechnology & Applied Microbiology

Systematic evaluation of colorectal cancer organoid system by single-cell RNA-Seq analysis

Rui Wang et al.

Summary: Patient-derived organoids can faithfully recapitulate the gene expression signatures of colorectal cancer cells in vivo, while organoids derived from normal tissues exhibit some tumor-like features but retain normal genomic features. Conditioned medium outperforms chemical-defined medium in long-term culture of tumor epithelial cells, and interchanging the culture medium does not significantly alter the transcriptome characteristics of the organoids.

GENOME BIOLOGY (2022)

Article Endocrinology & Metabolism

The gut microbial metabolite formate exacerbates colorectal cancer progression

Dominik Ternes et al.

Summary: This study reveals that formate, an oncometabolite produced by gut bacteria Fusobacterium nucleatum, promotes colorectal cancer (CRC) development by increasing cancer stemness and driving tumor invasion via AhR signaling.

NATURE METABOLISM (2022)

Article Oncology

Differential immune microenvironmental features of microsatellite-unstable colorectal cancers according toFusobacterium nucleatumstatus

Ji Ae Lee et al.

Summary: The study found that in MSI-high CRCs, tumors with high levels of Fn were correlated with larger size and more advanced invasion depth. Fn-high tumors showed lower density of FoxP3(+) cells throughout the tumor and an increased ratio of CD163(+)cells to CD68(+)cells in the CT area of MSI-high CRCs.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2021)

Review Biology

Non-coding RNAs: the new central dogma of cancer biology

Phei Er Saw et al.

Summary: Non-coding RNAs play crucial roles in cellular regulation and have been identified as key players in various networks, with both oncogenic and tumor suppressive functions in major cancers. Further understanding of ncRNAs could lead to more personalized therapeutic strategies.

SCIENCE CHINA-LIFE SCIENCES (2021)

Article Engineering, Biomedical

Hydrogel-based colorectal cancer organoid co-culture models

Xiaobei Luo et al.

Summary: This study developed a comprehensive three-dimensional model by establishing in vitro conditions for co-culturing colorectal cancer PDO and patient-derived CAFs, which helps to maintain the characteristics of tumor cells. Ultimately, this model is suitable for evaluating standard-of-care drugs and potentially useful for personalized cancer medicine.

ACTA BIOMATERIALIA (2021)

Review Medicine, Research & Experimental

EMT, cancer stem cells and autophagy; The three main axes of metastasis

Ghader Babaei et al.

Summary: Epithelial-mesenchymal transition (EMT) and Cancer stem-like cells (CSCs) are major factors contributing to cancer cell metastasis. Autophagy has recently gained attention, playing a dual role in cancer cell development depending on cancer type, tissue, and stage. Studies show different signaling pathways are involved in cancer stem cells, autophagy, and EMT. Investigating effective signaling pathways in all three processes could help determine appropriate therapeutic goals.

BIOMEDICINE & PHARMACOTHERAPY (2021)

Review Oncology

Fusobacterium nucleatum and oral cancer: a critical review

Emily McIlvanna et al.

Summary: There is a growing interest in the potential role inflammation plays in cancer initiation and progression, with examples such as Helicobacter pylori-mediated inflammation in gastric cancer and more recently, Fusobacterium nucleatum-mediated inflammation in colorectal cancer. Recent studies have shown that Fusobacterium nucleatum can promote cancer through multiple mechanisms, including activation of cell proliferation, promotion of cellular invasion, induction of chronic inflammation, and immune evasion, leading to hypotheses about its potential role in oral cancer development.

BMC CANCER (2021)

Article Oncology

ANGPTL4-Mediated Promotion of Glycolysis Facilitates the Colonization of Fusobacterium nucleatum in Colorectal Cancer

Xin Zheng et al.

Summary: The study reveals that F. nucleatum infection leads to increased expression of ANGPTL4 in colorectal cancer cells, promoting glucose uptake and glycolysis activity essential for colonization. Furthermore, increased acetylation of histone H3 lysine 27 is observed in F. nucleatum-infected cells and patient tumors, contributing to the transcriptional upregulation of ANGPTIA. This metabolic reprogramming induced by F. nucleaturn is crucial for its persistence in colorectal cancer and may serve as a potential target for clinical intervention.

CANCER RESEARCH (2021)

Article Gastroenterology & Hepatology

F. nucleatum targets lncRNA ENO1-IT1 to promote glycolysis and oncogenesis in colorectal cancer

Jie Hong et al.

Summary: The study revealed a positive correlation between Fusobacterium nucleatum and high glucose metabolism in patients with colorectal cancer (CRC), suggesting a potential role of gut microbiota in CRC development. Mechanistically, Fusobacterium nucleatum activated the lncRNA ENO1-IT1 pathway to regulate CRC cell glucose metabolism and biological functions. Targeting the ENO1 pathway may have therapeutic implications for CRC patients with elevated Fusobacterium nucleatum levels.
Review Oncology

The gastrointestinal microbiota in colorectal cancer cell migration and invasion

Charlotte Henstra et al.

Summary: Colorectal carcinoma is the third most common cancer in developed countries and the second leading cause of cancer-related mortality. Interest in the influence of intestinal microbiota on CRC has increased rapidly in recent years, with factors such as Fusobacterium nucleatum and Enterococcus faecalis contributing to disease progression by affecting cell-cell adhesion and the extracellular matrix. Understanding how bacterial factors promote CRC recurrence and metastasis is essential for improving patient survival, and further human-based models are needed to study these mechanisms.

CLINICAL & EXPERIMENTAL METASTASIS (2021)

Review Chemistry, Physical

Rethinking organoid technology through bioengineering

Elena Garreta et al.

Summary: Significant progress has been made in the differentiation of human pluripotent stem cells and the development of organoids. The convergence of stem cell biology and bioengineering allows for controlled stimuli to be provided to the system. Engineering solutions are emphasized to control the self-organization and functionality of stem cell-derived organoids.

NATURE MATERIALS (2021)

Article Microbiology

Fusobacterium nucleatum Promotes the Progression of Colorectal Cancer Through Cdk5-Activated Wnt/β-Catenin Signaling

Xiang Li et al.

Summary: This study demonstrates that Fusobacterium nucleatum abundance is significantly higher in CRC tissues and is closely associated with CRC progression. F. nucleatum enhances CRC cell proliferation and migration through activating Cdk5 and the Wnt/beta-catenin signaling pathway, revealing a novel mechanism for CRC development.

FRONTIERS IN MICROBIOLOGY (2021)

Article Oncology

The Potential of Colonic Tumor Tissue Fusobacterium nucleatum to Predict Staging and Its Interplay with Oral Abundance in Colon Cancer Patients

Pamela Pignatelli et al.

Summary: The study found that oral Fn concentration can influence colon tissue concentrations and predict the prognosis of colon cancer. Meat consumption is related to intestinal Fn, while Pg is not associated with colon cancer.

CANCERS (2021)

Article Immunology

Siglec-7 Mediates Immunomodulation by Colorectal Cancer-Associated Fusobacterium nucleatum ssp. animalis

Dimitra Lamprinaki et al.

Summary: The study reveals that F. nucleatum subspecies interacts with Siglecs on innate immune cells, with Siglec-7 being the most significant binding partner. By modulating the response of immune cells, F. nucleatum may promote the progression of colorectal cancer.

FRONTIERS IN IMMUNOLOGY (2021)

Review Pharmacology & Pharmacy

Tumor microenvironment as a therapeutic target in cancer

Yi Xiao et al.

Summary: This article summarizes the current progress in targeting the tumor microenvironment in both drug development and clinical trials, emphasizing the challenges in intervening in the tumor microenvironment and discussing strategies to maximize therapeutic benefits. New technologies and approaches to better understand the tumor microenvironment are explored in this context.

PHARMACOLOGY & THERAPEUTICS (2021)

Article Oncology

Relationship between Fusobacterium nucleatum and antitumor immunity in colorectal cancer liver metastasis

Yuki Sakamoto et al.

Summary: The presence of Fusobacterium nucleatum is associated with a lower density of CD8(+) T cells and a higher density of MDSCs in colorectal cancer liver metastases (CRLM) tissue. Further research is needed to potentially develop strategies targeting microbiota and immune cells for the prevention and treatment of CRLM.

CANCER SCIENCE (2021)

Article Cell Biology

Tumor-derived exosomes drive immunosuppressive macrophages in a pre-metastatic niche through glycolytic dominant metabolic reprogramming

Samantha M. Morrissey et al.

Summary: The study reveals that tumor-derived exosomes can polarize macrophages towards an immunosuppressive phenotype through NF-kB and glycolytic reprogramming, and are associated with lactate, GLUT-1, and YKT6 factors, further promoting tumor metastasis.

CELL METABOLISM (2021)

Review Genetics & Heredity

MiRNAs and Cancer: Key Link in Diagnosis and Therapy

Yu Shi et al.

Summary: The study of miRNA in cancer has made significant advancements, with research showing that miRNA can be dysregulated in different types of cancers and act as either tumor promoters or tumor suppressors. Studies have also revealed that miRNA may serve as novel tools and targets for therapeutic attempts, and the development of miRNA delivery systems has accelerated the preclinical implications of miRNA in cancer treatment.

GENES (2021)

Article Immunology

Fusobacterium nucleatum Facilitates M2 Macrophage Polarization and Colorectal Carcinoma Progression by Activating TLR4/NF-κB/S100A9 Cascade

Lijun Hu et al.

Summary: The research found that Fusobacterium nucleatum infection is closely associated with the development of colorectal cancer, primarily by promoting the polarization of M2 macrophages to exacerbate tumor malignancy. S100A9 is a key signaling molecule that regulates the activation of M2 macrophages. Targeting the TLR4/NF-kappa B/S100A9 cascade may serve as a promising therapeutic strategy for Fusobacterium nucleatum-associated colorectal cancer.

FRONTIERS IN IMMUNOLOGY (2021)

Review Cell Biology

Fusobacterium nucleatum Acts as a Pro-carcinogenic Bacterium in Colorectal Cancer: From Association to Causality

Shuang Wang et al.

Summary: This review summarizes the biological characteristics of Fusobacterium nucleatum (F. nucleatum) and its epidemiological associations with colorectal cancer (CRC), highlighting the mechanisms by which F. nucleatum participates in CRC progression, metastasis, and chemoresistance. The research gap in this field is discussed, and the authors provide their perspective for future studies. These findings suggest potential strategies for manipulating gut F. nucleatum to address CRC in the future.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Article Gastroenterology & Hepatology

Exosomes derived from Fusobacterium nucleatum-infected colorectal cancer cells facilitate tumour metastasis by selectively carrying miR-1246/92b-3p/27a-3p and CXCL16

Songhe Guo et al.

Summary: This study demonstrates that exosomes from Fn-infected cells deliver miR-1246/92b-3p/27a-3p and CXCL16/RhoA/IL-8 to non-infected cells, increasing cell migration ability in vitro and promoting tumor metastasis in vivo. Additionally, circulating exosomal levels of miR-1246/92b-3p/27a-3p and CXCL16 are closely associated with Fn abundance and tumor stage in colorectal cancer patients.
Review Biochemistry & Molecular Biology

DNA damage repair: historical perspectives, mechanistic pathways and clinical translation for targeted cancer therapy

Ruixue Huang et al.

Summary: Genomic instability is a characteristic of various cancers, with radiotherapy and chemotherapy in cancer treatment based on this property but also accompanied by adverse effects. Targeted cancer therapy has the potential to suppress cancer cells' DNA damage response by tailoring therapy to individual patients lacking specific DNA damage response functions, which is crucial for the emergence of promising druggable targets in the future.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)

Article Gastroenterology & Hepatology

Fusobacterium nucleatum promotes colorectal cancer metastasis through miR-1322/CCL20 axis and M2 polarization

Chaochao Xu et al.

Summary: In this study, it was found that F. nucleatum plays a crucial role in promoting CRC metastasis by activating CCL20 and inducing M2 macrophage polarization. Moreover, the regulatory micro-RNA miR-1322 was identified to be involved in this process by regulating CCL20.

GUT MICROBES (2021)

Review Gastroenterology & Hepatology

Influence of the Gut Microbiome, Diet, and Environment on Risk of Colorectal Cancer

Mingyang Song et al.

GASTROENTEROLOGY (2020)

Review Biochemistry & Molecular Biology

Regulatory Mechanism of MicroRNA Expression in Cancer

Zainab Ali Syeda et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Review Biochemistry & Molecular Biology

Cell adhesion in cancer: Beyond the migration of single cells

Michalina Janiszewska et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2020)

Article Gastroenterology & Hepatology

Fusobacterium nucleatum promotes colorectal cancer metastasis by modulating KRT7-AS/KRT7

Shujie Chen et al.

GUT MICROBES (2020)

Article Multidisciplinary Sciences

Colorectal cancer-associated anaerobic bacteria proliferate in tumor spheroids and alter the microenvironment

Stephen H. Kasper et al.

SCIENTIFIC REPORTS (2020)

Article Multidisciplinary Sciences

Breast cancer colonization by Fusobacterium nucleatum accelerates tumor growth and metastatic progression

Lishay Parhi et al.

NATURE COMMUNICATIONS (2020)

Review Biotechnology & Applied Microbiology

Progress in Understanding the IL-6/STAT3 Pathway in Colorectal Cancer

Yan Lin et al.

ONCOTARGETS AND THERAPY (2020)

Article Integrative & Complementary Medicine

Cinobufacini Inhibits Colon Cancer Invasion and Metastasis via Suppressing Wnt/beta-Catenin Signaling Pathway and EMT

Jie Wang et al.

AMERICAN JOURNAL OF CHINESE MEDICINE (2020)

Article Biochemistry & Molecular Biology

Fusobacterium nucleatum promotes colorectal cancer by inducing Wnt/β-catenin modulator Annexin A1

Mara Roxana Rubinstein et al.

EMBO REPORTS (2019)

Review Oncology

The Tumor Microenvironment Innately Modulates Cancer Progression

Dominique C. Hinshaw et al.

CANCER RESEARCH (2019)

Article Oncology

RUNX1 promotes tumour metastasis by activating the Wnt/β-catenin signalling pathway and EMT in colorectal cancer

Qingyuan Li et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)

Review Oncology

Tumor-derived exosomes, myeloid-derived suppressor cells, and tumor microenvironment

Xinyu Tian et al.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)

Review Biochemistry & Molecular Biology

Role of AKT and mTOR signaling pathways in the induction of epithelial-mesenchymal transition (EMT) process

Mostafa Karimi Roshan et al.

BIOCHIMIE (2019)

Review Medicine, General & Internal

Colorectal cancer

Evelien Dekker et al.

LANCET (2019)

Review Microbiology

Fusobacterium nucleatum - symbiont, opportunist and oncobacterium

Caitlin A. Brennan et al.

NATURE REVIEWS MICROBIOLOGY (2019)

Review Cell Biology

New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer

Anushka Dongre et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2019)

Review Nutrition & Dietetics

Colorectal Cancer and Nutrition

Kannan Thanikachalam et al.

NUTRIENTS (2019)

Article Medicine, Research & Experimental

MiR-454-3p-Mediated Wnt/beta-catenin Signaling Antagonists Suppression Promotes Breast Cancer Metastasis

Liangliang Ren et al.

THERANOSTICS (2019)

Review Biochemistry & Molecular Biology

DNA Damage, Mutagenesis and Cancer

Ashis K. Basu

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)

Review Pathology

Epithelial Mesenchymal Transition in Tumor Metastasis

Vivek Mittal

ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 13 (2018)

Review Biotechnology & Applied Microbiology

Targeting macrophages: therapeutic approaches in cancer

Luca Cassetta et al.

NATURE REVIEWS DRUG DISCOVERY (2018)

Article Biotechnology & Applied Microbiology

In vivo genome editing and organoid transplantation models of colorectal cancer and metastasis

Jatin Roper et al.

NATURE BIOTECHNOLOGY (2017)

Article Multidisciplinary Sciences

Analysis of Fusobacterium persistence and antibiotic response in colorectal cancer

Susan Bullman et al.

SCIENCE (2017)

Article Oncology

Myeloid-Derived Suppressor Cells

Dmitry I. Gabrilovich

CANCER IMMUNOLOGY RESEARCH (2017)

Article Cell Biology

Metabolism shapes the tumor microenvironment

Miguel Reina-Campos et al.

CURRENT OPINION IN CELL BIOLOGY (2017)

Review Biology

Stem-like features of cancer cells on their way to metastasis

Sofia Gkountela et al.

BIOLOGY DIRECT (2016)

Article Biochemistry & Molecular Biology

Prospective Derivation of a Living Organoid Biobank of Colorectal Cancer Patients

Marc van de Wetering et al.

Review Biochemistry & Molecular Biology

Targeting the DNA Damage Response in Cancer

Mark J. O'Connor

MOLECULAR CELL (2015)